A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/8883420

Download in:

View as

General Info

PMID
8883420